That is my thinking also, they are lining up for partnership of eli. I was thinking we would hear of FDA approvals first, but it now seems $eltp is about to announce something very big with the hk deal. Should he an awesome week next week. Imo.
" Could they(HONG KONG PHARMA) be the partner for ELI-216 and funding the Phase III trials??"
IMO The ELI-216 Phase III trials for the 300 persons could be in the +$6 mil range or approx $20,000 per person.
It would be best if a giant pharmaceutical like Watson/Actavis or Teva/Barr would partner with Elite by assuming 100% of the cost in return for a favorable licensing deal. To the giants the +$6 mil, 100%, would be "pocket change"